Dr. Jessica R. Allegretti is an Associate Professor of Medicine at Harvard Medical School and in addition currently serves as the Medical Director of the Crohn’s and Colitis Center at Brigham and Women’s Hospital, where she built and leads the Clinical Trials Program and Fecal Microbiota Transplant Program. She graduated from The Miller School of Medicine at the University of Miami in Miami, Florida, trained in internal medicine at Massachusetts’s General Hospital and completed her gastroenterology fellowship training at Brigham and Women’s Hospital before joining faculty there. She later went on to receive a Master of Public Health degree from the Harvard School of Public Health

She is a physician-scientist dedicated to discovering and developing innovative microbiome therapeutics and novel treatments for inflammatory bowel disease (IBD). Her research focus is on the mechanism of recurrent C.difficile infection (CDI) and the intersection of CDI and IBD. She has authored >100 peer-reviewed publications.  She has received funding from the NIH, the American College of Gastroenterology and the Crohn’s and Colitis Foundation. Dr. Allegretti has been featured on HBO, BBC, Netflix, and in the New York Times and numerous other media outlets. Dr. Allegretti has also received the Sherman Emerging Leader Prize for Excellence in Crohn’s and Colitis